CRDO
From Preclinical to Commercialization: A CRDO Approach to Accelerating Biologic Development
Matthias Lucke, Ph.D.; Ivonne Stelzl, Ph.D.
Coriolis Pharma
PAO-08-25-CL-02Aug 04, 2025
Gender Bias
Sex Differences, Gender Biases: What Are We Really Studying in Preclinical Research?
Serene Lee
Nice Insight
PAO-05-25-NI-12May 29, 2025
Sex Differences
Half the Data, Half the Science: The Cost of Ignoring Sex Differences in Preclinical Research
David Alvaro, Ph.D.
Pharma's Almanac
PAO-05-25-NI-05May 15, 2025
Virotherapy
Oncolytic Virotherapy: Real Potential and Difficult Challenges
Cynthia A. Challener, Ph.D.
Pharma's Almanac
PAO-12-24-CL-1Dec 02, 2024
Hematologic
Skyhawk Therapeutics to Present Preclinical Data of SKY-1214 Combination Treatment in Hematologic Cancers
Skyhawk
PR-11-24-NI-118Nov 21, 2024
Clinical Trials
Carisma Unveils Promising Pre-Clinical Data on Anti-GPC3 In Vivo CAR-M Therapy for Hepatocellular Carcinoma
Carisma Therapeutics Inc.
PR-10-24-NI-89Nov 08, 2024
Translation
The Translational Index Score: Improving the Entire Drug Development Cycle
Jo Varshney, Ph.D., D.V.M.
PAO-02-24-CL-10Feb 15, 2024
Failing Fast
Maximizing Resources and Potential for Success by Failing Fast
Nazar Elkarim, Ph.D.
Mikart
PAO-10-23-CL-02Oct 23, 2023
Expanded CDMO Capabilities
On the Journey to Support Drug Developers With End-to-End Outsourcing
Michelle Hall
Mikart
PAO-06-23-CL-04Jul 17, 2023
Preclinical Data
Transforming Drug Development with Frictionless Access to Real-Time Preclinical Data
Mark Mintz; Kristen M. Eisenhauer
Charles River Laboratories
PAO-05-23-CL-03May 05, 2023
Global License Agreement
Hovione and JIXING Announce an Exclusive Global License Agreement for Ophthalmology Program
Hovione
PR-M05-22-04May 09, 2022
Tissue Models
Developing a Robust In Vitro Intestinal Model for Preclinical Candidate Screening of GI Toxicity
Ron Laethem, Ph.D.
Altis Biosystems
PAO-02-21-CL-04Feb 18, 2021
Tissue Models
The Power of RepliGut In Vitro Intestinal Stem Cell Models
Bailey Zwarycz, Ph.D
Altis Biosystems
PA1081Jan 26, 2021
Preclinical
Increasing the Efficiency of Drug Development with Preclinical Testing Using Human Intestinal Stem Cells
Ron Laethem, Ph.D.
Altis Biosystems
PAO-11-20-CL-01Dec 09, 2020
Preclinical Data
Alligator Bioscience: New Preclinical Data Demonstrate Strong Anti-tumor Effects for the 4-1BB Antibody ATOR-1017
Nice Insight
PR-M03-19-NI-053Mar 20, 2019
Viral Vectors
Preclinical to Nearly Commercial Virus and Viral Vector Manufacturing
Jean Blehaut
Axplora
PAP-Q1-2019-CL-020Mar 12, 2019
Advisory Board
Kymera Therapeutics Announces Expansion of Scientific Advisory Board to Advance Pre-Clinical Molecules Toward the Clinic
Kymera Therapeutics
PR-M12-18-NI-079Dec 27, 2018
Preclinical Data
Encouraging Preclinical Data for Anticancer Drugs Reported by Verseon
Cynthia A. Challener, Ph.D.
Pharma's Almanac
PAO-M04-18-NI-019Apr 26, 2018
Preclinical Data
Syros Announces New Preclinical Data on SY-1365 Showing Potent Anti-Tumor Activity in Multiple Models of Heavily Pretreated Ovarian Cancer
Syros Pharmaceuticals
PR-M04-18-NI-67Apr 19, 2018
Preclinical Data
Tolero Pharmaceuticals to Present Preclinical Data Supporting Apoptosis-Inducing Activity of Alvocidib in Acute Myeloid Leukemia
Tolero Pharmaceuticals
PR-M04-18-NI-56Apr 17, 2018